Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
This page is not indexed by search engines while we improve data quality.
Paris Sciences Et Lettres—Quartier Latin — Human Necessities
Paris Sciences Et Lettres—Quartier Latin holds 6 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Paris Sciences Et Lettres—Quartier Latin |
| Technology | Human Necessities |
| Patents in slice | 6 |
| Recent patents in slice | 5 |
| First year | 2021 |
| Last year | 2025 |
Representative patents
Notable publications linking Paris Sciences Et Lettres—Quartier Latin to Human Necessities.
Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
Pneumatic structure and associated production method
US-12129907-B2 · Oct 29, 2024 · US
Recent filings
Latest patents from Paris Sciences Et Lettres—Quartier Latin in Human Necessities.
Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
Probenecid for use in treating epileptic diseases, disorders or conditions
US-12318358-B2 · Jun 3, 2025 · US
Pneumatic structure and associated production method
US-12129907-B2 · Oct 29, 2024 · US
Related pages
Navigate to parent entity pages.